|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farahmand M, Khademolhosseini F and
Mehrabani D: Trend of prostate cancer in Fars Province, Southern
Iran, 2001-2007. J Res Med Sci. 15:295–297. 2010.PubMed/NCBI
|
|
3
|
Talaiezadeh A, Tabesh H, Sattari A and
Ebrahimi S: Cancer incidence in southwest of iran: First report
from khuzestan population-based cancer registry, 2002–2009. Asian
Pac J Cancer Prev. 14:7517–7522. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baade PD, Youlden DR, Cramb SM, Dunn J and
Gardiner RA: Epidemiology of prostate cancer in the Asia-Pacific
region. Prostate Int. 1:47–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ntais C, Polycarpou A and Tsatsoulis A:
Molecular epidemiology of prostate cancer: Androgens and
polymorphisms in androgen-related genes. Eur J Endocrinol.
149:469–477. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chokkalingam AP, Stanczyk FZ, Reichardt JK
and Hsing AW: Molecular epidemiology of prostate cancer:
Hormone-related genetic loci. Front Biosci. 12:3436–3460. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou X, Wei L, Jiao G, Gao W, Ying M, Wang
N, Wang Y and Liu C: The association between the APE1 Asp148Glu
polymorphism and prostate cancer susceptibility: A meta-analysis
based on case-control studies. Mol Genet Genomics. 290:281–288.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bratt O: Hereditary prostate cancer:
Clinical aspects. J Urol. 168:906–913. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lichtenstein P, Holm NV, Verkasalo PK,
Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki
K: Environmental and heritable factors in the causation of
cancer-analyses of cohorts of twins from Sweden, Denmark, and
Finland. N Engl J Med. 343:78–85. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang Q, Whitington T, Gao P, Lindberg JF,
Yang Y, Sun J, Väisänen MR, Szulkin R, Annala M, Yan J, et al: A
prostate cancer susceptibility allele at 6q22 increases RFX6
expression by modulating HOXB13 chromatin binding. Nat Genet.
46:126–135. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hazelett DJ, Rhie SK, Gaddis M, Yan C,
Lakeland DL and Coetzee SG: Ellipse/GAME-ON consortium; Practical
consortium. Henderson BE, Noushmehr H, et al: Comprehensive
functional annotation of 77 prostate cancer risk loci. PLoS Genet.
10:e10041022014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eeles RA, Olama AA, Benlloch S, Saunders
EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C,
Dennis J, Jugurnauth-Little S, et al: Identification of 23 new
prostate cancer susceptibility loci using the iCOGS custom
genotyping array. Nat Genet. 45:385–91, 391e1-2. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
16
|
Sibin MK, Harshitha SM, Narasingarao KV,
Dhananjaya IB, Dhaval PS and Chetan GK: Effect of rs11614913
polymorphism on mature miR196a2 Expression and its target gene
HOXC8 expression in human glioma. J Mol Neurosci. 61:144–151. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashemi M, Danesh H, Bizhani F, Narouie B,
Sotoudeh M, Nouralizadeh A, Sharifiaghdas F, Bahari G and Taheri M:
Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate
cancer. Cancer Biomark. 18:155–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hashemi M, Moradi N, Ziaee SA, Narouie B,
Soltani MH, Rezaei M, Shahkar G and Taheri M: Association between
single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and
miR-149 and prostate cancer risk in a sample of Iranian population.
J Adv Res. 7:491–498. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu F, Dear K, Huang L, Liu L, Shi Y, Nie
S, Liu Y, Lu Y and Xiang H: Association between microRNA-27a
rs895819 polymorphism and risk of colorectal cancer: A
meta-analysis. Cancer Genet. 209:388–394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Li L, Yin Z, Zhang Q, Zhao H, Tao
R, Wang S, Hu S, He Y, Wang D, et al: An Indel Polymorphism within
pre-miR3131 confers risk for hepatocellular carcinoma.
Carcinogenesis. 38:168–176. 2017.PubMed/NCBI
|
|
21
|
Omrani M, Hashemi M, Eskandari-Nasab E,
Hasani SS, Mashhadi MA, Arbabi F and Taheri M: hsa-mir-499
rs3746444 gene polymorphism is associated with susceptibility to
breast cancer in an Iranian population. Biomark Med. 8:259–267.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mullaney JM, Mills RE, Pittard WS and
Devine SE: Small insertions and deletions (INDELs) in human
genomes. Hum Mol Genet. 19:R131–R136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eskandari-Nasab E, Hashemi M, Ebrahimi M
and Amininia S: The functional 4-bp insertion/deletion ATTG
polymorphism in the promoter region of NF-KB1 reduces the risk of
BC. Cancer Biomark. 16:109–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hashemi M, Shahkar G, Simforoosh N, Basiri
A, Ziaee SA, Narouie B and Taheri M: Association of polymorphisms
in PRKCI gene and risk of prostate cancer in a sample of Iranian
Population. Cell Mol Biol (Noisy-le-grand). 61:16–21.
2015.PubMed/NCBI
|
|
25
|
Hashemi M, Hanafi Bojd H, Eskandari Nasab
E, Bahari A, Hashemzehi NA, Shafieipour S, Narouie B, Taheri M and
Ghavami S: Association of Adiponectin rs1501299 and rs266729 gene
polymorphisms with nonalcoholic fatty liver disease. Hepat Mon.
13:e95272013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luu HN, Lin HY, Sørensen KD, Ogunwobi OO,
Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, et al:
miRNAs associated with prostate cancer risk and progression. BMC
Urol. 17:182017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei W, Leng J, Shao H and Wang W: MiR-1, a
potential predictive biomarker for recurrence in prostate cancer
after radical prostatectomy. Am J Med Sci. 353:315–319. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Valentino A, Reclusa P, Sirera R,
Giallombardo M, Camps C, Pauwels P, Crispi S and Rolfo C: Exosomal
microRNAs in liquid biopsies: Future biomarkers for prostate
cancer. Clin Transl Oncol. 19:651–657. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shukla KK, Misra S, Pareek P, Mishra V,
Singhal B and Sharma P: Recent scenario of microRNA as diagnostic
and prognostic biomarkers of prostate cancer. Urol Oncol.
35:92–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu X and Dou Y: miR-1307 promotes the
proliferation of prostate cancer by targeting FOXO3A. Biomed
Pharmacother. 88:430–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chu H, Zhong D, Tang J, Li J, Xue Y, Tong
N, Qin C, Yin C, Zhang Z and Wang M: A functional variant in
miR-143 promoter contributes to prostate cancer risk. Arch Toxicol.
90:403–414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Porkka KP, Ogg EL, Saramaki OR, Saramäki
OR, Vessella RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M,
Kallioniemi OP, et al: The miR-15a-miR-16-1 locus is homozygously
deleted in a subset of prostate cancers. Genes Chromosomes Cancer.
50:499–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen J, Park HS, Xia YM, Kim GS and Cui
SW: The polysaccharides from fermented Ganoderma lucidum mycelia
induced miRNAs regulation in suppressed HepG2 cells. Carbohydr
Polym. 103:319–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek
SH and Kim VN: MicroRNA genes are transcribed by RNA polymerase II.
EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hashemi M, Bahari G, Naderi M,
Sadeghi-Bojd S and Taheri M: Pri-miR-34b/c rs4938723 polymorphism
is associated with the risk of childhood acute lymphoblastic
leukemia. Cancer Genet. 209:493–496. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Okubo M, Tahara T, Shibata T, Yamashita H,
Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T and
Hirata I: Association between common genetic variants in
pre-microRNAs and gastric cancer risk in Japanese population.
Helicobacter. 15:524–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiu F, Yang L, Zhang L, Yang X, Yang R,
Fang W, Wu D, Chen J, Xie C, Huang D, et al: Polymorphism in mature
microRNA-608 sequence is associated with an increased risk of
nasopharyngeal carcinoma. Gene. 565:180–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hashemi M, Sanaei S, Rezaei M, Bahari G,
Hashemi SM, Mashhadi MA, Taheri M and Ghavami S: miR-608 rs4919510
C>G polymorphism decreased the risk of breast cancer in an
Iranian subpopulation. Exp Oncol. 38:57–59. 2016.PubMed/NCBI
|
